Development of Biofunctional 3D-Printed Orthodontic Aligners With Antimicrobial and Remineralizing Properties
3D-BIOALIGN
1 other identifier
interventional
400
1 country
1
Brief Summary
Clear orthodontic aligners are widely used due to their esthetics and patient comfort; however, prolonged wear may promote biofilm accumulation and enamel demineralization. This laboratory-based (in vitro) study aims to develop and evaluate a novel directly 3D-printed orthodontic aligner resin modified with antimicrobial and remineralizing agents. The study will investigate the incorporation of dimethylaminohexadecyl methacrylate (DMAHDM) as an antibacterial agent and amorphous calcium phosphate (ACP) as a remineralizing component into a 3D-printed aligner resin. Modified and unmodified resin specimens will be fabricated and assessed for antimicrobial activity, ion release, and enamel remineralization potential using extracted human teeth. In addition, the mechanical and physical properties of the experimental aligner materials, including shape memory behavior, deflection, tensile strength, translucency, and water sorption, will be evaluated to ensure clinical suitability. This study does not involve human participants and is conducted entirely in vitro. The findings are expected to contribute to the development of biofunctional orthodontic aligners that actively inhibit bacterial growth and support enamel health without compromising material performance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
Study Completion
Last participant's last visit for all outcomes
February 1, 2027
May 22, 2026
May 1, 2026
6 months
April 24, 2026
May 15, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Antimicrobial Activity of Modified 3D-Printed Aligner Resin
Evaluation of antibacterial effectiveness by quantifying Streptococcus mutans biofilm using colony-forming unit (CFU) counts (CFU/mL
day 1
Enamel Remineralization Assessed by Raman Spectroscopy
Assessment of mineral content changes in enamel adjacent to aligner material using Raman spectroscopy (e.g., phosphate ν1 peak intensity at \~960 cm-¹).
day 7
Ion Release from Modified Aligner Resin
Quantification of calcium (Ca²⁺) and phosphate (PO₄³-) ion release using inductively coupled plasma (ICP) analysis (ppm)
day 7
Secondary Outcomes (5)
Tensile Properties of Modified 3D-Printed Aligner Resin
After specimen fabrication and post-curing (Day 1)
Flexural Properties of Modified 3D-Printed Aligner Resin
(Day 1)
Shape Memory
day 1
Water Sorption and Solubility
day 1 to day 7
Optical Properties: Translucency
day 1
Study Arms (4)
control group
EXPERIMENTALDirectly 3D-printed orthodontic aligner resin
DMAHDM group
EXPERIMENTALDirectly 3D-printed orthodontic aligner resin with incorporation of dimethylaminohexadecyl methacrylate (DMAHDM)
ACP group
EXPERIMENTALDirectly 3D-printed orthodontic aligner resin with incorporation of Amorphous calcium phosphate (ACP)
DMAHDM + ACP group
EXPERIMENTALDirectly 3D-printed orthodontic aligner resin with incorporation both DMAHDM and ACP
Interventions
Directly 3D-printed orthodontic aligner resin with or without incorporation of antimicrobial (DMAHDM) and remineralizing (ACP) agents.
Eligibility Criteria
You may qualify if:
- Extracted human teeth obtained for reasons unrelated to this study (e.g., orthodontic or periodontal indications).
- Teeth collected after obtaining ethical approval from the Research Ethics Committee.
- Teeth free from visible cracks, fractures, restorations, or developmental defects.
You may not qualify if:
- \- Teeth with caries, restorations, cracks, fractures, or structural defects.
- Teeth extracted due to pathological conditions affecting enamel or dentin integrity.
- Teeth with unknown extraction history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Dentistry, University of Baghdad
Baghdad, Baghdad Governorate, 1417, Iraq
Study Officials
- STUDY CHAIR
Ali I Ibrahim, Prof. Dr
University of Baghdad
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- postgraduate/PhD student
Study Record Dates
First Submitted
April 24, 2026
First Posted
May 22, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
participants confidentiality